Drug Side Effect Profiles as Molecular Descriptors for Predictive Modeling of Target Bioactivity

By  

MOLECULAR INFORMATICS, Vol. 34, Iss. 2‐3, 2015-02 ,pp. : 160-170

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Paradigm Shift in Pharmacokinetic–Pharmacodynamic (PKPD) Modeling: Rule of Thumb for Estimating Free Drug Level in Tissue Compared with Plasma to Guide Drug Design

By  

JOURNAL OF PHARMACEUTICAL SCIENCES (ELECTRONIC), Vol. 104, Iss. 7, 2015-07 ,pp. : 2359-2368

John Wiley & Sons Inc

Access to resources Recommend Favorite

Probability Issues in Molecular Design: Predictive and Modeling Ability in 3D-QSAR Schemes

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 7, Iss. 8, 2004-12 ,pp. : 793-807

Bentham Science Publishers

Access to resources Recommend Favorite

Peptidomimetics for Bridging Structure and Function: Pseudo-Prolines (ΨPro) in Peptide Synthesis, Molecular Recognition, and Drug Design

By Tuchscherer Gabriele   Mutter Manfred  

CHIMIA International Journal for Chemistry, Vol. 55, Iss. 4, 2001-04 ,pp. : 306-313

Swiss Chemical Society

Access to resources Recommend Favorite

Molecular Modeling of Mercury Porosimetry

By Porcheron F.   Monson P.   Thommes M.  

Adsorption, Vol. 11, Iss. 1, 2005-07 ,pp. : 325-329

Springer Publishing Company

Access to resources Recommend Favorite